181 related articles for article (PubMed ID: 23144724)
1. Englerin a selectively induces necrosis in human renal cancer cells.
Sulzmaier FJ; Li Z; Nakashige ML; Fash DM; Chain WJ; Ramos JW
PLoS One; 2012; 7(10):e48032. PubMed ID: 23144724
[TBL] [Abstract][Full Text] [Related]
2. Renal cancer-selective Englerin A induces multiple mechanisms of cell death and autophagy.
Williams RT; Yu AL; Diccianni MB; Theodorakis EA; Batova A
J Exp Clin Cancer Res; 2013 Aug; 32(1):57. PubMed ID: 23958461
[TBL] [Abstract][Full Text] [Related]
3. Total synthesis of englerin A.
Nicolaou KC; Kang Q; Ng SY; Chen DY
J Am Chem Soc; 2010 Jun; 132(23):8219-22. PubMed ID: 20496885
[TBL] [Abstract][Full Text] [Related]
4. Englerin A Agonizes the TRPC4/C5 Cation Channels to Inhibit Tumor Cell Line Proliferation.
Carson C; Raman P; Tullai J; Xu L; Henault M; Thomas E; Yeola S; Lao J; McPate M; Verkuyl JM; Marsh G; Sarber J; Amaral A; Bailey S; Lubicka D; Pham H; Miranda N; Ding J; Tang HM; Ju H; Tranter P; Ji N; Krastel P; Jain RK; Schumacher AM; Loureiro JJ; George E; Berellini G; Ross NT; Bushell SM; Erdemli G; Solomon JM
PLoS One; 2015; 10(6):e0127498. PubMed ID: 26098886
[TBL] [Abstract][Full Text] [Related]
5. Englerin A induces an acute inflammatory response and reveals lipid metabolism and ER stress as targetable vulnerabilities in renal cell carcinoma.
Batova A; Altomare D; Creek KE; Naviaux RK; Wang L; Li K; Green E; Williams R; Naviaux JC; Diccianni M; Yu AL
PLoS One; 2017; 12(3):e0172632. PubMed ID: 28296891
[TBL] [Abstract][Full Text] [Related]
6. (-)-Englerin A is a potent and selective activator of TRPC4 and TRPC5 calcium channels.
Akbulut Y; Gaunt HJ; Muraki K; Ludlow MJ; Amer MS; Bruns A; Vasudev NS; Radtke L; Willot M; Hahn S; Seitz T; Ziegler S; Christmann M; Beech DJ; Waldmann H
Angew Chem Int Ed Engl; 2015 Mar; 54(12):3787-91. PubMed ID: 25707820
[TBL] [Abstract][Full Text] [Related]
7. Tonantzitlolone cytotoxicity toward renal cancer cells is PKCθ- and HSF1-dependent.
Sourbier C; Scroggins BT; Mannes PZ; Liao PJ; Siems K; Wolf D; Beutler JA; Linehan WM; Neckers L
Oncotarget; 2015 Oct; 6(30):29963-74. PubMed ID: 26298773
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of a stable and orally bioavailable englerin analogue.
Fash DM; Peer CJ; Li Z; Talisman IJ; Hayavi S; Sulzmaier FJ; Ramos JW; Sourbier C; Neckers L; Figg WD; Beutler JA; Chain WJ
Bioorg Med Chem Lett; 2016 Jun; 26(11):2641-4. PubMed ID: 27107948
[TBL] [Abstract][Full Text] [Related]
9. Total synthesis and biological evaluation of (-)-englerin A and B: synthesis of analogues with improved activity profile.
Radtke L; Willot M; Sun H; Ziegler S; Sauerland S; Strohmann C; Fröhlich R; Habenberger P; Waldmann H; Christmann M
Angew Chem Int Ed Engl; 2011 Apr; 50(17):3998-4002. PubMed ID: 21472928
[No Abstract] [Full Text] [Related]
10. Englerin A, a selective inhibitor of renal cancer cell growth, from Phyllanthus engleri.
Ratnayake R; Covell D; Ransom TT; Gustafson KR; Beutler JA
Org Lett; 2009 Jan; 11(1):57-60. PubMed ID: 19061394
[TBL] [Abstract][Full Text] [Related]
11. Englerin A Rewires Phosphosignaling via Hsp27 Hyperphosphorylation to Induce Cytotoxicity in Renal Cancer Cells.
Neo SP; Alli-Shaik A; Wee S; Lim Z; Gunaratne J
J Proteome Res; 2022 Aug; 21(8):1948-1960. PubMed ID: 35838755
[TBL] [Abstract][Full Text] [Related]
12. Formal synthesis of (-)-englerin A and cytotoxicity studies of truncated englerins.
Xu J; Caro-Diaz EJ; Batova A; Sullivan SD; Theodorakis EA
Chem Asian J; 2012 May; 7(5):1052-60. PubMed ID: 22415793
[TBL] [Abstract][Full Text] [Related]
13. Asymmetric Total Synthesis of (-)-Englerin A through Catalytic Diastereo- and Enantioselective Carbonyl Ylide Cycloaddition.
Hanari T; Shimada N; Kurosaki Y; Thrimurtulu N; Nambu H; Anada M; Hashimoto S
Chemistry; 2015 Aug; 21(33):11671-6. PubMed ID: 26179743
[TBL] [Abstract][Full Text] [Related]
14. Chlorinated englerins with selective inhibition of renal cancer cell growth.
Akee RK; Ransom T; Ratnayake R; McMahon JB; Beutler JA
J Nat Prod; 2012 Mar; 75(3):459-63. PubMed ID: 22280462
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and Biological Evaluation of New (-)-Englerin Analogues.
López-Suárez L; Riesgo L; Bravo F; Ransom TT; Beutler JA; Echavarren AM
ChemMedChem; 2016 May; 11(9):1003-7. PubMed ID: 27005578
[TBL] [Abstract][Full Text] [Related]
16. Chemical synthesis of the englerins.
Pouwer RH; Richard JA; Tseng CC; Chen DY
Chem Asian J; 2012 Jan; 7(1):22-35. PubMed ID: 22162365
[TBL] [Abstract][Full Text] [Related]
17. A brief synthesis of (-)-englerin A.
Li Z; Nakashige M; Chain WJ
J Am Chem Soc; 2011 May; 133(17):6553-6. PubMed ID: 21476574
[TBL] [Abstract][Full Text] [Related]
18. Shape Similarity by Fractal Dimensionality: An Application in the de novo Design of (-)-Englerin A Mimetics.
Friedrich L; Byrne R; Treder A; Singh I; Bauer C; Gudermann T; Mederos Y Schnitzler M; Storch U; Schneider G
ChemMedChem; 2020 Apr; 15(7):566-570. PubMed ID: 32162837
[TBL] [Abstract][Full Text] [Related]
19. Unveiling (-)-Englerin A as a Modulator of L-Type Calcium Channels.
Rodrigues T; Sieglitz F; Somovilla VJ; Cal PM; Galione A; Corzana F; Bernardes GJ
Angew Chem Int Ed Engl; 2016 Sep; 55(37):11077-81. PubMed ID: 27391219
[TBL] [Abstract][Full Text] [Related]
20. Triple-negative breast cancer cell line sensitivity to englerin A identifies a new, targetable subtype.
Grant CV; Carver CM; Hastings SD; Ramachandran K; Muniswamy M; Risinger AL; Beutler JA; Mooberry SL
Breast Cancer Res Treat; 2019 Sep; 177(2):345-355. PubMed ID: 31230251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
